Investor profile
Schroder Adveq has backed 2 European tech companies across 2 funding rounds between 2021 and 2022, joining rounds totalling €121M. Most active in Fintech and Cybersecurity. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Immunos Therapeutics | Switzerland | 1 | €68M |
| Tessian | UK | 1 | €53M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Immunos Therapeutics | Series B | €68M | 2022-06 |
| Tessian | Series C | €53M | 2021-05 |
